NYHA FC II | NYHA FC III | |
---|---|---|
Anthropometrics (Clinical characteristics) | ||
Subjects (N (%)) | 66 (57) | 49 (43) |
Gender (M/F) | 56/10 | 38/11 |
Median age (y) (interquartile range) | 56 (50–62)* | 62 (57–71) |
Height (cm) | 166.4 ± 7.6 | 163.1 ± 8.5 |
Weight (kg) | 71.0 ± 14.9 | 71.1 ± 19.1 |
BMI (kg/m2) | 25.5 ± 4.4 | 26.6 ± 6.3 |
HR (beats/min) | 73 ± 11 | 71 ± 12 |
SBP (mmHg) | 123 ± 22 | 122 ± 22 |
DBP (mmHg) | 77 ± 13 | 72 ± 15 |
NYHA Fc (from clinician) | 2.6 ± 0.5 | 2.5 ± 0.5 |
Echocardiography | ||
LVEF (%) | 43.5 ± 14.1 | 39.5 ± 13.6 |
Exercise performance at peak phase | ||
Work-rate (Watts) | 115 ± 27* | 75 ± 22 |
HR (beats/min) | 144 ± 21* | 118 ± 22 |
MBP (mmHg) | 115 ± 17* | 102 ± 15 |
VE (L/min) | 61.0 ± 14.7* | 46.1 ± 14.0 |
VO2peak (mL/min/kg) | 20.7 ± 3.7* | 14.0 ± 2.3 |
VE- VCO2 slope | 31.25 ± 4.67* | 37.14 ± 8.58 |
OUES | 709.1 ± 173.1* | 525.8 ± 164.4 |
Quality of Life | ||
SF-36 | ||
PCS | 51.44 ± 6.73* | 45.26 ± 8.54 |
MCS | 48.52 ± 9.40* | 42.64 ± 11.10 |
MLHFQ | 16.5 ± 12.9* | 25.3 ± 19.2 |
TCM inquiry | 50.6 ± 29.6* | 76.0 ± 53.2 |